14800-DvRappard

72 Chapter 4 16. Bonouvrie L, Becher J, Soudant D, Buizer A, van Ouwerkerk W, Vles G, et al. The effect of intrathecal baclofen treatment on activities of daily life in children and young adults with cerebral palsy and progressive neurological disorders. Eur J Paediatr Neurol . 2016;20:538-44. 17. Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil . 2005;86:2165-2171. 18. Bonouvrie LA, Becher JG, Vles JS, Boeschoten K, Soudant D, de Groot V, et al. Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial. BMC Pediatr . 2013;13:175. 19. Bonouvrie LA, van Schie PE, Becher JG, van Ouwerkerk WJ, Vermeulen RJ. Intrathecal baclofen for progressive neurological disease in childhood: a systematic review of literature . Eur J Paediatr Neurol. 2012;16:279-284. 20. Albright AL, Barry MJ, Fasick P, Barron W, Shultz B. Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery . 1996;38:934-938; discussion 8-9. 21. van Hulst BM TP, de Groot V, van Ouwerkerk WJ, Vermeulen RJ, Becher JG, Peerdeman SM. Complicaties bij kinderen met intrathecale baclofentherapie en (gerelateerde) verzorgertevredenheid. Tijdschrift voor kindergeneeskunde. 2009;77:191–7. 22. Ward A, Hayden S, Dexter M, Scheinberg A. Continuous intrathecal baclofen for children with spasticity and/or dystonia: Goal attainment and complications associated with treatment. J Paediatr Child Health . 2009;45:720-726.